» Authors » Gianluca Rosso

Gianluca Rosso

Explore the profile of Gianluca Rosso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 549
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosso G, Porceddu G, Portaluppi C, Garrone C, Salvo G, Maina G
Psychiatry Res . 2025 Mar; 347:116422. PMID: 40023095
Aim: This cross-sectional observational study aimed to assess objective and subjective cognitive deficits in patients with unipolar (UD) and bipolar depression (BD), focusing on their insight into actual cognitive abilities....
2.
Rosso G, dAndrea G, Barlati S, Di Nicola M, Andriola I, Marcatili M, et al.
Curr Neuropharmacol . 2025 Jan; 23(5):e1570159X337670. PMID: 39810448
Introduction/objective: Data on long-term treatment with Esketamine Nasal Spray (ESKNS) in real-world patients with treatment resistant depression (TRD) is scarce. The primary aim of the study is to evaluate the...
3.
Salvo G, Perotti C, Filippo L, Garrone C, Rosso G, Maina G
Ann Gen Psychiatry . 2024 Nov; 23(1):42. PMID: 39487473
Background: The association between Attention-deficit hyperactivity disorder (ADHD) and suicidality has been subject of growing interest for research in the latest years. Suicidality was generally assessed categorically and without the...
4.
Rosso G, Benatti B, Pettorruso M, Sampogna G, Tomasetti C
Front Psychiatry . 2024 Sep; 15:1362221. PMID: 39267701
Depressive disorders are leading contributors to the global mental health-related burden, and they represent a challenge for real-world clinicians, due to the low rates of remission despite the high availability...
5.
Rizzo Pesci N, Teobaldi E, Maina G, Rosso G
Int J Environ Res Public Health . 2024 Jul; 21(7). PMID: 39063403
Background: Psychiatric disorders are large contributors to the global disease burden, but research on the impact of climate change on them is limited. Our aim is to investigate the correlation...
6.
Salvo G, Perotti C, Ricci V, Maina G, Rosso G
Trends Psychiatry Psychother . 2024 Apr; PMID: 38687843
Introduction: Recent guidelines on depressive disorders suggest a combination of antidepressants and psychotherapy in case of moderate to severe symptomatology. While cognitive behavioral therapy and interpersonal therapy are the most...
7.
Teobaldi E, Pessina E, Martini A, Cattaneo C, de Berardis D, Martiadis V, et al.
Curr Neuropharmacol . 2024 Jan; 22(10):1742-1748. PMID: 38288838
Background: Treatment-resistant bipolar depression is one of the leading problems in psychiatry with serious consequences on patients functioning, quality of life and resource utilization. Despite this, there is a lack...
8.
Castellini G, Tarchi L, Cassioli E, Ricca V, Abbate Daga G, Aguglia A, et al.
Acta Psychiatr Scand . 2024 Jan; 149(3):177-194. PMID: 38167781
Background: A better characterization of educational processes during psychiatry training is needed, both to foster personal resilience and occupational proficiency. Methods: An adequate coverage of medical residents at the national...
9.
dAndrea G, Pettorruso M, Di Lorenzo G, Rhee T, Chiappini S, Carullo R, et al.
J Affect Disord . 2023 Dec; 348:314-322. PMID: 38145840
Introduction: Intravenous ketamine (KET-IV) and intranasal esketamine (ESK-NS) are effective in the acute treatment of Treatment-Resistant Depression (TRD). Studies comparing KET-IV and ESK-NS concerning their action, safety, and tolerability are...
10.
Fiorillo A, Sampogna G, Albert U, Maina G, Perugi G, Pompili M, et al.
Ann Gen Psychiatry . 2023 Dec; 22(1):50. PMID: 38057894
Background: Bipolar disorder is one of the most burdensome severe mental disorders, characterized by high levels of personal and social disability. Patients often need an integrated pharmacological and non-pharmacological approach....